HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DP1 Activation Reverses Age-Related Hypertension Via NEDD4L-Mediated T-Bet Degradation in T Cells.

AbstractBACKGROUND:
Blood pressure often rises with aging, but exact mechanisms are still not completely understood. With aging, the level of proinflammatory cytokines increases in T lymphocytes. Prostaglandin D2, a proresolution mediator, suppresses Type 1 T helper (Th1) cytokines through D-prostanoid receptor 1 (DP1). In this study, we aimed to investigate the role of the prostaglandin D2/DP1 axis in T cells on age-related hypertension.
METHODS:
To clarify the physiological and pathophysiological roles of DP1 in T cells with aging, peripheral blood samples were collected from young and older male participants, and CD4+ T cells were sorted for gene expression, prostaglandin production, and Western blot assays. Mice blood pressure was quantified by invasive telemetric monitor.
RESULTS:
The prostaglandin D2/DP1 axis was downregulated in CD4+ T cells from older humans and aged mice. DP1 deletion in CD4+ T cells augmented age-related hypertension in aged male mice by enhancing Th1 cytokine secretion, vascular remodeling, CD4+ T cells infiltration, and superoxide production in vasculature and kidneys. Conversely, forced expression of exogenous DP1 in T cells retarded age-associated hypertension in mice by reducing Th1 cytokine secretion. Tumor necrosis factor α neutralization or interferon γ deletion ameliorated the age-related hypertension in DP1 deletion in CD4+ T cells mice. Mechanistically, DP1 inhibited Th1 activity via the PKA (protein kinase A)/p-Sp1 (phosphorylated specificity protein 1)/neural precursor cell expressed developmentally downregulated 4-like (NEDD4L) pathway-mediated T-box-expressed-in-T-cells (T-bet) ubiquitination. T-bet deletion or forced NEDD4L expression in CD4+ T cells attenuated age-related hypertension in CD4+ T cell-specific DP1-deficient mice. DP1 receptor activation by BW245C prevented age-associated blood pressure elevation and reduced vascular/renal superoxide production in male mice.
CONCLUSIONS:
The prostaglandin D2/DP1 axis suppresses age-related Th1 activation and subsequent hypertensive response in male mice through increase of NEDD4L-mediated T-bet degradation by ubiquitination. Therefore, the T cell DP1 receptor may be an attractive therapeutic target for age-related hypertension.
AuthorsDeping Kong, Qiangyou Wan, Juanjuan Li, Shengkai Zuo, Guizhu Liu, Qian Liu, Chenchen Wang, Peiyuan Bai, Sheng-Zhong Duan, Bin Zhou, Fotini Gounari, Ankang Lyu, Michael Lazarus, Richard M Breyer, Ying Yu
JournalCirculation (Circulation) Vol. 141 Issue 8 Pg. 655-666 (02 25 2020) ISSN: 1524-4539 [Electronic] United States
PMID31893939 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antihypertensive Agents
  • Cytokines
  • Receptors, Prostaglandin
  • Sp1 Transcription Factor
  • T-Box Domain Proteins
  • T-box transcription factor TBX21
  • Superoxides
  • Nedd4 Ubiquitin Protein Ligases
  • Nedd4l protein, mouse
  • Cyclic AMP-Dependent Protein Kinases
  • Prostaglandin D2
Topics
  • Aged
  • Aging
  • Animals
  • Antihypertensive Agents (therapeutic use)
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • Cyclic AMP-Dependent Protein Kinases (metabolism)
  • Cytokines (metabolism)
  • Humans
  • Hypertension (drug therapy, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Nedd4 Ubiquitin Protein Ligases (metabolism)
  • Prostaglandin D2 (metabolism)
  • Receptors, Prostaglandin (agonists, deficiency, genetics, metabolism)
  • Signal Transduction
  • Sp1 Transcription Factor (metabolism)
  • Superoxides (metabolism)
  • T-Box Domain Proteins (metabolism)
  • Th1 Cells (metabolism)
  • Ubiquitination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: